tradingkey.logo

SNWV

SNWV
查看详细走势图
31.020USD
-1.230-3.81%
收盘 12/22, 16:00美东报价延迟15分钟
266.03M总市值
亏损市盈率 TTM

SNWV

31.020
-1.230-3.81%
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

-3.81%

5天

-1.96%

1月

-6.62%

6月

-7.90%

今年开始到现在

0.00%

1年

0.00%

查看详细走势图

TradingKey SNWV股票评分

单位: USD 更新时间: 2025-12-22

操作建议

SANUWAVE Health Inc当前公司基本面数据相对健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名98/208位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价54.00。中期看,股价处于平稳状态。近一个月,市场表现较差,但公司基本面和技术面得分较高。目前股价在压力位和支撑位之间,可以做区间波段操作。

SNWV评分

相关信息

行业排名
98 / 208
全市场排名
234 / 4578
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

分析师目标

根据 2 位分析师
买入
评级
54.000
目标均价
+80.72%
涨幅空间
数据免责声明:分析师评级与目标价由LSEG提供,仅供参考,不应当作投资建议

SNWV亮点

亮点风险
Sanuwave Health, Inc. is an ultrasound and shock wave technology company. It is a provider of wound care products. It is focused on the research, development, and commercialization of its patented, non-invasive, and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. It applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, and aesthetic/cosmetic. Its two primary systems are UltraMIST and PACE. The UltraMIST system provides, through a fluid mist, low-frequency, non-contact, and pain free ultrasound energy deep inside the wound bed that promotes healing. The PACE systems use acoustic pressure shockwaves generated by the Company's Pulsed Acoustic Cellular Expression technology to converge at precise selected targets to produce short duration compression burst and are used in both wound and orthopedic applications under the brand names dermaPACE and others.
业绩高增长
公司营业收入稳步增长,连续3年增长94.92%
业绩增长期
公司处于发展阶段,最新年度总收入32.63M美元
利润高增长
公司净利润处于行业前列,最新年度总收入32.63M美元
估值低估
公司最新PE估值-60.01,处于3年历史低位
机构加仓
最新机构持股4.71M股,环比增加15.21%
先锋集团持仓
明星投资者先锋集团持仓,最新持仓市值440.28K

SNWV新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

SNWV简介

Sanuwave Health, Inc. is an ultrasound and shock wave technology company. It is a provider of wound care products. It is focused on the research, development, and commercialization of its patented, non-invasive, and biological response-activating medical systems for the repair and regeneration of skin, musculoskeletal tissue, and vascular structures. It applies and researches its patented energy transfer technologies in wound healing, orthopedic/spine, and aesthetic/cosmetic. Its two primary systems are UltraMIST and PACE. The UltraMIST system provides, through a fluid mist, low-frequency, non-contact, and pain free ultrasound energy deep inside the wound bed that promotes healing. The PACE systems use acoustic pressure shockwaves generated by the Company's Pulsed Acoustic Cellular Expression technology to converge at precise selected targets to produce short duration compression burst and are used in both wound and orthopedic applications under the brand names dermaPACE and others.
公司代码SNWV
公司SANUWAVE Health Inc
CEOFrank (Morgan C)
网址https://sanuwave.com/

常见问题

SNWV(SNWV)的当前股价是多少?

SNWV(SNWV)的当前股价是 31.020。

SNWV的股票代码是什么?

SNWV的股票代码是SNWV。

SNWV股票的52周最高点是多少?

SNWV股票的52周最高点是46.585。

SNWV股票的52周最低点是多少?

SNWV股票的52周最低点是20.500。

SNWV的市值是多少?

SNWV的市值是266.03M。

SNWV的净利润是多少?

SNWV的净利润为-31.37M。

现在SNWV(SNWV)的股票是买入、持有还是卖出?

根据分析师评级,SNWV(SNWV)的总体评级为买入,目标价格为54.000。

SNWV(SNWV)股票的每股收益(EPS TTM)是多少

SNWV(SNWV)股票的每股收益(EPS TTM)是-0.517。
KeyAI